Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 6Warts 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Human Papillomavirus-Related Cervical Carcinoma 1Human Papillomavirus-Related Carcinoma 1Hematologic Neoplasms 1HIV Infections 1Condylomata Acuminata 1Acquired Immunodeficiency Syndrome 1

Interventions

pomalidomide 2liposomal doxorubicin 2plerixafor 1abemaciclib 1Watchful Waiting 1Vincristine 1Transurethral Resection of Prostate 1Self Care 1Rituximab 1Proctoscopy 1Prednisone 1Paclitaxel 1Nivolumab 1Maraviroc 1Human Papillomavirus Recombinant Vaccine nonavalent 1Focus Groups 1Fluorouracil 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Colposcopy 1Blood Specimen Collection 1Benzethonium 1Anti-HIV Agents 1Amyloid 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Human Papillomavirus Recombinant Vaccine nonavalent × 1 year × Clear all
NCT04982614 2025-08-24

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Columbia University

Phase 4 Completed
1,403 enrolled

Acquired Immunodeficiency Syndrome, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡